enVVeno Medical (NVNO) Interest Expenses (2021)

enVVeno Medical (NVNO) recorded quarterly Interest Expenses of $867.0 in Q2 2021, down 97.32% quarter-over-quarter from $32405.0 in Q1 2021.

enVVeno Medical (NVNO) Interest Expenses (2021) Analysis & Trends

enVVeno Medical's Interest Expenses history runs 1 years deep, the most recent figure standing at $867.0 for Q2 2021.

In Q2 2021, Interest Expenses changed N/A year-over-year to $867.0; the TTM figure through Mar 2022 stood at $867.0 (down 97.32% YoY), while the FY2020 annual figure was $215906.0, changed N/A from the prior year.
Interest Expenses was $867.0 for Q2 2021 at enVVeno Medical, down from $32405.0 in the prior quarter.
In the past five years, Interest Expenses ranged from a high of $32405.0 in Q1 2021 to a low of $867.0 in Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int Expense (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	174.00 Mn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	148.00 Mn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	181.00 Mn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	90.00 Mn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-97.17 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	96.00 Mn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	15.10 Mn
10	enVVeno Medical	6.86 Mn	6.86 Mn	-	-

Download Data